Wenn das Ergebnis vor der Auseinandersetzung mit den Fakten feststeht, kommt es selten gut im Journalismus. So auch jüngst in der «Sonntagszeitung», als diese von überdurchschnittlich linken SRG-Journalisten zu berichten wusste. Eine Aussage, die sich mit den verwendeten Zahlen nicht treffen lässt. Filip Dingerkus, Mitautor der Studie, auf die sich die Zeitung beruft, zeigt auf, wie der Artikel eigentlich hätte aussehen müssen.
On sait depuis 2016 que Facebook rémunère tant des personnalités que des médias pour produire des contenus sur son réseau social. Cette stratégie est désormais aussi à l’œuvre auprès des médias français (TF1, Le Figaro, Le Parisien, Le Monde, etc.) pour la production de vidéos, révèle l’enquête de Nicolas Becquet. Ces partenariats peuvent représenter jusqu’à 200’000 euros mensuels par titre. Une pratique qui pose la question de la dépendance des rédactions et ouvre la voie à un système à deux vitesses pénalisant les petits médias. Facebook assume, mais minimise l’importance de ce type de partenariat.
A majority of Americans rely on general outlets for science news but more say specialty sources get the facts right about science. At a time when scientific information is increasingly at the center of public divides, most Americans say they get science news no more than a couple of times per month, and when they do, most say it is by happenstance rather than intentionally, according to a new study by Pew Research Center. Overall, about a third, 36%, of Americans get science news at least a few times a week, three-in-ten actively seek it out, and a smaller portion, 17%, do both.
Oldies but goodies: The BBC’s science correspondent Pallab Ghosh gives students his top 10 tips for reporting on science stories. Best of all maybe No. 10: «Enjoy yourself. You get to talk to fascinating people about some of the most interesting stories of our time. Science journalism is the best job in the world. Savour every moment.»
Lately, NBC Nightly News ran a story about the cancer risks related to alcohol consumption, citing big scary numbers like an 500% increase of cancer risk for heavy drinkers, but without providing any context around these statistics. What does it really mean and how worried should viewers be? How should medical news not be reported? And how could it be reported in a credible, nuanced fashion?
Researchers say they can train computers to identify sexual orientation and criminality by scanning a person’s face. But to critics it’s just plain bad science. – On the first day of school, a child looks into a digital camera linked to the school’s computer. Upon a quick scan, the machine reports that the child’s facial contours indicate a likelihood toward aggression, and she is tagged for extra supervision. Not far away, another artificial intelligence screening system scans a man’s face. It deduces from his brow shape that he is likely to be introverted, and he is rejected for a sales job. Plastic surgeons, meanwhile, find themselves overwhelmed with requests for a “perfect” face that doesn’t show any “bad” traits.
Der «Beobachter» ist ein wichtiges, professionell gemachtes Printprodukt im Bereich der Lebenshilfe, das als Ratgeber funktioniert und gut recherchierte Reportagen publiziert. Vor kurzem leistete sich das Blatt aber einen Sündenfall der gröberen Art. Es wollte wissenschaftliche Erklärungen für übersinnliche Phänomene abgeben.
For quite some time, the words “the future is now” have been chasing us. Our collective imagination envisions a tomorrow filled with holograms, interactive media and 3D images. But when we look around, we realize that day may not come soon. However, one thing has visibly changed: digital content is more present than ever. Science magazines have slowly seized this opportunity. The first non-profit independent digital science magazine, Grist, was created in 1999. Nearly two decades later, the challenge to engage with a young, demanding public—and to be financially self-sufficient—still lingers. The fit should be perfect: communicating science and technologythrough science and technology. But as discussed by five journalists in the panel “The Rise of Digital Science Magazines” on 27 October at the World Conference of Science Journalists 2017, this is not the case.
“What’s your position on Tic-Tox?” Bruno Titotto asked while seeing Dr. François Goehringer, an infectious disease specialist, for the first time. We are in a new specialized Lyme disease clinic in Nancy, in northeast France. Tic-Tox is an alternative treatment of “essential oils,” marketed to those who believe they have a chronic form of Lyme disease. It was pulled from the French market in 2012 by a regulator for safety concerns, and Titotto’s question was not an innocent one. He was essentially asking Goehringer which side of the chronic Lyme debate he was on.
Rather than quieting the concerns of Lyme advocates, France’s national plan is further entrenching two extremes.
Titotto, a 30-something native of Lorraine, which has one of the highest rates of Lyme disease in France, has had odd symptoms for years: joint pains, intense fatigue, and difficulty with balance and memory. After searching on the internet, he thought something called chronic Lyme disease — a nebulous condition not recognized by most physicians — might explain his current symptoms. But his blood tests don’t offer a clear diagnosis.
“I’m not sure if what you have is really Lyme,” Goehringer told him.
That answer is unsatisfying for the legion of French citizens who have become convinced that chronic Lyme disease is real, and that doctors and scientists are flat out wrong. To fight this, the French government released a national plan to combat Lyme last year that included a fact-based public service campaign aimed at raising awareness about the disease’s real prevalence, and, it was hoped, dispelling misconceptions about chronic Lyme.
WHEN HENRY MOLAISON DIED at a Connecticut nursing home in 2008, at the age of 82, a front-page obituary in The New York Times called him “the most important patient in the history of brain science.” It was no exaggeration: Much of what we know about how memory works is derived from experiments on Molaison, a patient with severe epilepsy who in 1953 had undergone an operation that left him without medial temporal lobes and the ability to form new memories.